Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
QVPClass II

Sars-Cov-2 Serology Test

21 CFR 866.3983 / Microbiology

QVP is the FDA product code for Sars-Cov-2 Serology Test, a class II device type, regulated under 21 CFR 866.3983. FDA's definition for this code reads: "A SARS-CoV-2 serology test is a prescription in vitro diagnostic device for the detection of specific binding antibodies to SARS-CoV-2 in clinical specimens. The detection of SARS-CoV-2 antibodies is intended to aid in identifying individuals with an adaptive immune response to SARS-CoV-2. The test is not intended for...". As of , FDA records hold 5 510(k) clearances under this code, the most recent dated , and no recalls.

Classification record

Product code
QVP
Device name
Sars-Cov-2 Serology Test
FDA definition
A SARS-CoV-2 serology test is a prescription in vitro diagnostic device for the detection of specific binding antibodies to SARS-CoV-2 in clinical specimens. The detection of SARS-CoV-2 antibodies is intended to aid in identifying individuals with an adaptive immune response to SARS-CoV-2. The test is not intended for the diagnosis of acute SARS-CoV-2 infection, nor screening blood, plasma, cells, or tissue donors.
Regulation
21 CFR 866.3983
Device class
Class II
Review panel
Microbiology
Submission type
510(k)
Implant
No
Life sustaining or supporting
No
GMP exempt
No
Third party review eligible
No
Ingested clearances
5
Ingested recalls
0

Clearances, product code QVP

By decision year
5 clearances under product code QVP with a decision year between 2023 and 2026, 2023 the highest year at 2.
Show the numbers
510(k) clearances under FDA product code QVP by decision year
YearClearances
20232
20252
20261

Applicants with the most clearances

Product code QVP
Applicants holding the most 510(k) clearances under product code QVP
ApplicantClearances
Roche Diagnostics GmbH3
Ortho-Clinical Diagnostics, Inc.2

Companies listing this code with FDA

Companies whose registered establishments list this code